tiprankstipranks
Trending News
More News >
Engene Holdings Inc. (ENGN)
NASDAQ:ENGN
US Market

Compare enGene Holdings (ENGN) vs. Competitors

Compare
263 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
enGene Holdings
$10.64
$609.56M
53.09%
7 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$4.83
$43.44M
-0.49
-66.32%
2 Buy
3 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$24.17
$1.32B
-13.44
62.21%
8 Buy
0 Hold
0 Sell
Strong Buy
Replimune Group
$7.90
$549.89M
-2.19
-39.32%
1 Buy
2 Hold
0 Sell
Moderate Buy
Immuneering
$4.85
$308.64M
-2.99
153.08%
4 Buy
0 Hold
0 Sell
Strong Buy
Contineum Therapeutics, Inc. Class A
$12.20
$432.87M
-5.60
12.67%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ENGN
enGene Holdings
10.64
3.35
45.95%
TVRD
Tvardi Therapeutics
4.83
-10.35
-68.18%
CAPR
Capricor Therapeutics
24.17
9.64
66.35%
REPL
Replimune Group
7.90
-5.85
-42.55%
IMRX
Immuneering
5.34
3.19
148.37%
CTNM
Contineum Therapeutics, Inc. Class A
12.63
1.35
11.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts